NASDAQ: PGACPantages Capital Acqusition Corp Stock
$10.26+0.00 (+0%)
Updated Sep 26, 2025
PGAC Price
$10.26
Fair Value Price
N/A
Market Cap
$113.12M
52 Week Low
$9.89
52 Week High
$10.29
P/E
102.6x
P/B
-149.81x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$1.32M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.55
Operating Cash Flow
-$554k
Beta
-0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PGAC Overview
Pantages Capital Acquisition Corporation. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Aifeex Nexus Acquisition Corporation and changed its name to Pantages Capital Acquisition Corporation. in August 2025. Pantages Capital Acquisition Corporation. was incorporated in 2024 and is based in Wilmington, Delaware.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PGAC's potential to beat the market
- PGAC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
PGAC
RankedUnranked of 29
RankedUnranked of 29
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.40 | C | |
| $9.94 | C | |
| $10.12 | C |
Be the first to know about important PGAC news, forecast changes, insider trades & much more!
PGAC News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PGAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PGAC is poor value based on its earnings relative to its share price (102.6x), compared to the US market average (36.62x)
P/E vs Market Valuation
PGAC is poor value based on its earnings relative to its share price (102.6x), compared to the US Shell Companies industry average (6.84x)
P/E vs Industry Valuation
PGAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more PGAC due diligence checks available for Premium users.
Valuation
PGAC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
102.6x
Industry
6.84x
Market
36.62x
PGAC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PGAC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PGAC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-149.81x
Industry
-52.85x
PGAC's financial health
Profit margin
Revenue
$0.0
Net Income
$723.2k
Profit Margin
0%
PGAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$88.7M
Liabilities
$1.2M
Debt to equity
-1.55
PGAC's short-term assets ($414.94k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PGAC's long-term liabilities ($862.50k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PGAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PGAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$153.8k
Investing
$0.0
Financing
$0.0
PGAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PGAC vs Shell Company Stocks
Pantages Capital Acqusition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.